GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (OTCPK:INVVY) » Definitions » Cyclically Adjusted PB Ratio

Indivior (Indivior) Cyclically Adjusted PB Ratio : (As of May. 18, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Indivior Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Indivior's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Cyclically Adjusted PB Ratio Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 190.82

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 190.82 268.49

Competitive Comparison of Indivior's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Indivior's Cyclically Adjusted PB Ratio falls into.



Indivior Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Indivior's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Indivior's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.073/131.7762*131.7762
=0.073

Current CPI (Mar. 2024) = 131.7762.

Indivior Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 -3.305 99.070 -4.396
201503 -2.839 99.621 -3.755
201506 -2.324 100.684 -3.042
201509 -2.011 100.392 -2.640
201512 -1.941 99.792 -2.563
201603 -1.600 100.470 -2.099
201606 -1.159 101.688 -1.502
201609 -2.651 101.861 -3.430
201612 -2.047 101.863 -2.648
201703 -1.464 102.862 -1.876
201706 -0.922 103.349 -1.176
201709 -0.513 104.136 -0.649
201712 -1.407 104.011 -1.783
201803 -0.694 105.290 -0.869
201806 -0.295 106.317 -0.366
201809 0.330 106.507 0.408
201812 0.453 105.998 0.563
201903 0.914 107.251 1.123
201906 1.404 108.070 1.712
201909 1.724 108.329 2.097
201912 1.430 108.420 1.738
202003 0.266 108.902 0.322
202006 0.396 108.767 0.480
202009 0.545 109.815 0.654
202012 0.559 109.897 0.670
202103 1.116 111.754 1.316
202106 1.585 114.631 1.822
202109 1.113 115.734 1.267
202112 1.445 117.630 1.619
202203 1.643 121.301 1.785
202206 1.647 125.017 1.736
202209 1.648 125.227 1.734
202212 0.374 125.222 0.394
202303 0.522 127.348 0.540
202306 0.849 128.729 0.869
202309 -0.174 129.860 -0.177
202312 9.646 129.419 9.822
202403 0.073 131.776 0.073

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Indivior  (OTCPK:INVVY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Indivior Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Indivior's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Indivior (Indivior) Business Description

Traded in Other Exchanges
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.